Breast adenocarcinoma
MONDO:0004988A carcinoma that arises from glandular epithelial cells of the breast
Also known as: adenocarcinoma of breast, adenocarcinoma of the breast, breast adenocarcinoma, mammary adenocarcinoma
3063 clinical trials for this condition and its sub-types, 36 tagged with Breast adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Breast adenocarcinoma
-
Breast ductal adenocarcinoma 18 trials · 191 incl. sub-types
4 sub-types
- Ductal breast carcinoma in situ 152 trials Sub-types →
- Invasive ductal breast carcinoma 41 trials · 48 incl. sub-types Sub-types →
- Breast papillary carcinoma 1 trial Sub-types →
- Breast apocrine carcinoma 0 trials
-
Breast lobular carcinoma 13 trials · 34 incl. sub-types
2 sub-types
-
Inflammatory breast carcinoma 29 trials
-
Lobular breast carcinoma in situ 27 trials
-
1 sub-type
-
Adenoid cystic breast carcinoma 0 trials
-
Breast malignant eccrine spiradenoma 0 trials
-
Breast mucinous cystadenocarcinoma 0 trials
-
Mammary Paget disease 0 trials
1 sub-type
- Paget disease of the nipple 0 trials
-
Mucoepidermoid breast carcinoma 0 trials
-
Oncocytic breast carcinoma 0 trials
-
Sebaceous breast carcinoma 0 trials
-
Signet ring cell breast carcinoma 0 trials
Most studied deeper sub-types
-
Immunotherapy combo tested for aggressive breast cancer – trial stopped early
Disease control Stopped earlyThis phase 3 trial tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy and HER2-targeted therapy could help people with HER2-positive breast cancer that has spread. The study enrolled 190 participants but was terminated early, so the full results ar…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene study may explain why some breast cancers resist hormone therapy
Knowledge-focused Stopped earlyThis study looked at whether a specific gene mutation (HSD3B1) changes how well the hormone therapy letrozole works in postmenopausal women with early-stage, hormone-sensitive breast cancer. Researchers measured changes in tumor markers before and after treatment. The trial was e…
Phase 4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC